FDA wants yet more data on Takeda diabetes drug alogliptin

Article Date: 26/04/2012 10:00
FDA wants yet more data on Takeda diabetes drug alogliptin

Vacancy Search

Quick job search

Advanced Search

Latest News

EU clears Novartis-GSK mega deal

EU clears Novartis-GSK mega deal

1.2m UK adults could have wrong asthma diagnosis

1.2m UK adults could have wrong asthma diagnosis

UK's largest biorepository opens in Milton Keynes

UK's largest biorepository opens in Milton Keynes

Obama calls for $1.2 billion to tackle antibiotic resistance

Obama calls for $1.2 billion to tackle antibiotic resistance

Merck & Co and Novo sign up to TransCelerate

Merck & Co and Novo sign up to TransCelerate

Novartis in talks to sell Horsham site to Brighton University

Novartis in talks to sell Horsham site to Brighton University

GPs to issue info prescriptions for uncontrolled diabetes

GPs to issue info prescriptions for uncontrolled diabetes

Breast cancer drugs drive solid growth for Roche

Breast cancer drugs drive solid growth for Roche

NHS England asks: what treatments should we be investing in?

NHS England asks: what treatments should we be investing in?

Amgen/Onyx file multiple myeloma drug in US, EU

Amgen/Onyx file multiple myeloma drug in US, EU
more news